Sugi Predict

Sugi Predict / Compounds / SCHEMBL1762503

SCHEMBL1762503

SCHEMBL1762503

CC(=O)c1cc([N+](=O)[O-])ccc1Cl

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 6/20 0.61
▸ RORC P51449 6/20 0.61
▸ MEN1 O00255 4/20 0.61
▸ SMN1; SMN2 Q16637 3/20 0.61
▸ CYP3A4 P08684 2/20 0.61
▸ MAPT P10636 2/20 0.61
▸ MAPK1 P28482 2/20 0.61
▸ PPARG P37231 2/20 0.61
▸ LMNA P02545 1/20 0.61
▸ TP53 P04637 1/20 0.61
▸ CYP1A2 P05177 1/20 0.61
▸ CYP2D6 P10635 1/20 0.61
▸ CYP2C9 P11712 1/20 0.61
▸ PKM P14618 1/20 0.61
▸ TSHR P16473 1/20 0.61
▸ NFKB1 P19838 1/20 0.61
▸ CYP2C19 P33261 1/20 0.61
▸ THPO P40225 1/20 0.61
▸ MTOR P42345 1/20 0.61
▸ PMP22 Q01453 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16954410 0.87 HSD17B10 (0.60) KMT2ARORCMEN1SMN1; SMN2CYP3A4
SCHEMBL480106 0.86 KMT2A (0.70) KMT2AMEN1SMN1; SMN2MAPTMAPK1
SCHEMBL10953243 0.85 HSD17B10 (0.62) KMT2ARORCMEN1SMN1; SMN2CYP3A4
SCHEMBL14850045 0.85 RORC (0.54) KMT2ARORCMEN1SMN1; SMN2CYP3A4
SCHEMBL14732029 0.84 HSD17B10 (0.61) KMT2ARORCMEN1SMN1; SMN2CYP3A4
SCHEMBL4090795 0.84 HSD17B10 (0.56) KMT2ARORCMEN1SMN1; SMN2CYP3A4
SCHEMBL398463 0.84 HSD17B10 (0.60) KMT2ARORCMEN1SMN1; SMN2CYP3A4
SCHEMBL231222 0.84 KMT2A (0.63) KMT2ARORCMEN1SMN1; SMN2CYP3A4
SCHEMBL3656114 0.83 MAPK1 (0.57) KMT2ARORCMEN1SMN1; SMN2CYP3A4
SCHEMBL9551017 0.82 KMT2A (0.55) KMT2ARORCMEN1SMN1; SMN2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 163 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240270747-A1 HETEROARYL PYRIDONE AND AZA-PYRIDONE COMPOUNDS GENENTECH, INC. (US) 2024-08-15 — — US disclosed
US-20230279012-A1 HETEROARYL PYRIDONE AND AZA-PYRIDONE COMPOUNDS GENENTECH, INC. (US) 2023-09-07 — — US disclosed
US-11433061-B2 Heteroaryl sulfonamides and CCR2/CCR9 CHEMOCENTRYX, INC. (US) 2022-09-06 — — US disclosed
US-11433061-B2 Heteroaryl sulfonamides and CCR2/CCR9 CHEMOCENTRYX, INC. (US) 2022-09-06 — — US disclosed
EP-4050012-A1 PYRIDONE BORONATES FOR THE PREPARATION OF INHIBITORS OF BTK ACTIVITY F. Hoffmann-La Roche AG (CH) 2022-08-31 — — EP disclosed
EP-4019508-A1 HETEROARYL PYRIDONE AND AZA-PYRIDONE COMPOUNDS AS INHIBITORS OF BTK ACTIVITY F. Hoffmann-La Roche AG (CH) 2022-06-29 — — EP disclosed
EP-3521288-B1 HETEROARYL PYRIDONE AND AZA-PYRIDONE COMPOUNDS AS INHIBITORS OF BTK ACTIVITY HOFFMANN LA ROCHE (CH) 2021-09-08 — — EP disclosed
CN-111056994-B Preparation method of vismodegib 新发药业有限公司 2021-08-17 — — CN disclosed
CN-111056994-B Preparation method of vismodegib 新发药业有限公司 2021-08-17 — — CN disclosed
CN-109071488-B Substituted 1,2, 3-triazoles as NR 2B-selective NMDA modulators 詹森药业有限公司 2021-08-13 — — CN disclosed
US-5523278-A PRE- AND POST-EMERGENCE HERBICIDES AMERICAN CYANAMID COMPANY (US) 1996-06-04 — — US disclosed
US-5484763-A Substituted benzisoxazole and benzisothiazole herbicidal agents AMERICAN CYANAMID COMPANY (US) 1996-01-16 — — US disclosed
US-5336663-A 3-aryluracil derivatives and their use for weed control CIBA-GEIGY CORPORATION (US) 1994-08-09 — — US disclosed
EP-0542685-A1 3-Aryluracile derivatives and their use against weeds CIBA-GEIGY AG (CH) 1993-05-19 — — EP disclosed
US-5053325-A 2-hydrogen bond donating group-substituted benzoyl acetanilides KONICA CORPORATION (JP) 1991-10-01 — — US disclosed
EP-0422505-A1 Silver halide color photographic light-sensitive material KONICA CORPORATION (JP) 1991-04-17 — — EP disclosed
US-4996139-A Silver halide photographic light-sensitive material containing novel cyan coupler KONICA CORPORATION (JP) 1991-02-26 — — US disclosed
EP-0354549-A2 Silver halide photographic lightsensitive material containing novel cyan coupler KONICA CORPORATION (JP) 1990-02-14 — — EP disclosed
US-4202696-A Method of removing surface tack of cured free radical polymerized resin composition using organic carbonyl compound ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1980-05-13 — — US disclosed
US-4036838-A Process for the production of nitro derivatives of aromatic compounds BAYER AKTIENGESELLSCHAFT (DT) 1977-07-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11433061-B2 Heteroaryl sulfonamides and CCR2/CCR9 CCR2, CCR9, CCR1 KMT2A 2475/4885RORC 145/4885MEN1 4873/4885
US-20240270747-A1 HETEROARYL PYRIDONE AND AZA-PYRIDONE COMPOUNDS PDXK, BTK, TYK2 KMT2A 2237/4885RORC 464/4885MEN1 2841/4885
US-20230279012-A1 HETEROARYL PYRIDONE AND AZA-PYRIDONE COMPOUNDS PDXK, BTK, TYK2 KMT2A 2237/4885RORC 464/4885MEN1 2841/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.